Available Until 6/3/2029

Medications for Opioid Use Disorder (MOUD) Training Program

ACPE NumbersPending for pharmacists and physicians
Release Date
: June 3, 2026 - currently available to pre-order
Expiration Date: June 3, 2029

Activity Type: Application-based
Activity Fee: ASHP Member: $225 | Non-Member: $325
 

Overview

The Medications for Opioid Use Disorder (MOUD) Training Program is self-guided, with online learning activities that have been created for pharmacists, physicians, and other advanced healthcare professionals who work or plan to work with medications for opioid use disorder. 

The opioid crisis continues to take lives every day—yet evidence-based treatment remains underutilized. Medications for Opioid Use Disorder (MOUD) are proven to save lives, reduce overdose risk, and support long-term recovery, but only when clinicians are prepared to use them effectively. 

This training program equips healthcare professionals with the knowledge, skills, and confidence to deliver high-quality MOUD care across practice settings. Through practical, clinically relevant instruction, learners gain a deeper understanding of treatment principles, patient-centered approaches, and best practices for managing opioid use disorder. 

This training program was designed to meet the Substance Abuse and Mental Health Services Administration (SAMHSA) training requirements for the Medication Access and Training Expansion (MATE) Act of 2023.

Medications for Opioid Use Disorders (MOUD) Training Program Requirement

Once a learner has completed the educational curriculum, they will have the opportunity to complete an online comprehensive exam. Once the learner passes the exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the statement of completion for the training program.